| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1219-1228, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
IC Le Poole, RM van den Wijngaard, W Westerhof and PK Das
Department of Dermatology, Academic Medical Center, Amsterdam University, The Netherlands.
Evidence for the involvement of cellular immunity in the etiopathogenesis of the hypopigmentary disorder vitiligo is provided by rare cases of inflammatory vitiligo. Nonlesional, perilesional, and lesional skin biopsies from three inflammatory vitiligo patients were immunohistochemically analyzed. The composition of inflammatory infiltrates present in perilesional skin was analyzed by antibodies to T cells (CD2, CD3, CD4, and CD8), Langerhans cells (CD1a), and macrophages (CD36 and CD68). The presence of activation markers on inflammatory cells was evaluated by analysis of HLA-DR, interleukin-2 receptor, and HECA452 expression. The presence or absence of melanocytes was determined by the antibody NKI-beteb. Moreover, the abundance of matrix molecule tenascin was semi-quantified using T2H5. Results indicate that within perilesional skin, epidermis-infiltrating T cells exhibit an increased CD8/CD4 ratio and increased cutaneous lymphocyte antigen and interleukin-2 receptor expression. These cells are frequently juxtapositionally apposed to remaining melanocytes. In perilesional dermis, CD68+OKM5- macrophages were more numerous than in lesional or nonlesional skin. Keratinocytes as well as melanocytes consistently express major histocompatibility complex class II antigens along stretches of basal and suprabasal layers in perilesional epidermis. Moreover, inflammation is accompanied by increased tenascin content. Although these observations do not permit differentiation between the immune infiltrates being a result as opposed to the cause of the disease process, results presented in this study are very suggestive of involvement of local immune reactivity in melanocyte destruction.
This article has been cited by other articles:
![]() |
T. Lambe, J. C. H. Leung, T. Bouriez-Jones, K. Silver, K. Makinen, T. L. Crockford, H. Ferry, J. V. Forrester, and R. J. Cornall CD4 T Cell-Dependent Autoimmunity against a Melanocyte Neoantigen Induces Spontaneous Vitiligo and Depends upon Fas-Fas Ligand Interactions. J. Immunol., September 1, 2006; 177(5): 3055 - 3062. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Plettenberg, T. Assmann, and T. Ruzicka Childhood Vitiligo and Tacrolimus: Immunomodulating Treatment for an Autoimmune Disease Arch Dermatol, May 1, 2003; 139(5): 651 - 654. [Full Text] [PDF] |
||||
![]() |
S. H. Jackman, S. Keerthy, and G. Perry Murine Epidermal Cell Antigen (Skn)-Directed Autoimmunity Induced by Transfer of CD4+ T Cells Ann. Clin. Lab. Sci., April 1, 2002; 32(2): 171 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wallner, C. Li, P. K. Shah, M. C. Fishbein, J. S. Forrester, S. Kaul, and B. G. Sharifi Tenascin-C Is Expressed in Macrophage-Rich Human Coronary Atherosclerotic Plaque Circulation, March 16, 1999; 99(10): 1284 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Ogg, P. Rod Dunbar, P. Romero, J.-L. Chen, and V. Cerundolo High Frequency of Skin-homing Melanocyte-specific Cytotoxic T Lymphocytes in Autoimmune Vitiligo J. Exp. Med., September 21, 1998; 188(6): 1203 - 1208. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |